- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06913452
Effect of Obesity on Tear Film and Ocular Health Among Diabetic Patients
March 29, 2025 updated by: Muhammad Naveed Babur, Superior University
To evaluate the effect of obesity on tear film and ocular health in diabetic patients.
Research Design An observational cross-sectional study will be conducted.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Actual)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Mandi Bahāuddīn, Punjab, Pakistan
- Alvi Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Diabetic participants aged 18-70 with varying BMI categories will be assessed for tear production and film stability using Schirmer's Test and Tear Break-Up Time (TBUT).
Demographics, medical history, and ocular health will also be recorded in a controlled clinic environment.
Description
Inclusion Criteria:
- Adults (18+ years)
- diagnosed with type 1 or type 2 diabetes
- categorized as obese or non-obese (BMI >30 or <30)
- stable glycemic control, and willing to provide consent.
Exclusion Criteria:
- Non-diabetic individuals
- pregnant/lactating women
- those with recent ocular surgeries
- systemic medications affecting tear film, or severe unrelated diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Oswestry Disability Index (ODI)
Time Frame: 12 Months
|
The Oswestry Disability Index (ODI) is a questionnaire used to assess functional disability in individuals with low back pain, with scores ranging from 0% (no disability) to 100% (maximum disability), and interpreted as follows: 0-20% minimal disability, 21-40% moderate, 41-60% severe, 61-80% crippling, and 81-100% bed-bound or exaggerated symptom
|
12 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2025
Primary Completion (Estimated)
June 20, 2025
Study Completion (Estimated)
February 20, 2026
Study Registration Dates
First Submitted
March 29, 2025
First Submitted That Met QC Criteria
March 29, 2025
First Posted (Actual)
April 6, 2025
Study Record Updates
Last Update Posted (Actual)
April 6, 2025
Last Update Submitted That Met QC Criteria
March 29, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSRSW/Batch-Fall23/800
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.